113 related articles for article (PubMed ID: 38044218)
1. Integrated network pharmacology and metabolomics reveal the action mechanisms of vincristine combined with celastrol against colon cancer.
Ning JY; Ma B; Huang JY; Han L; Shao YH; Wang FY
J Pharm Biomed Anal; 2024 Feb; 239():115883. PubMed ID: 38044218
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miRNA-14669 Reverses Vincristine Resistance in Colorectal Cancer Cells through PI3K/AKT Signaling Pathway.
Dong W; Wang F; Liu Q; Wang T; Yang Y; Guo P; Li X; Wei B
Recent Pat Anticancer Drug Discov; 2022; 17(2):178-186. PubMed ID: 34365931
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and in vivo studies reveal the pharmacological effects and molecular mechanisms of Celastrol against acute hepatic injury induced by LPS.
Yang T; Zhao S; Sun N; Zhao Y; Wang H; Zhang Y; Hou X; Tang Y; Gao X; Fan H
Int Immunopharmacol; 2023 Apr; 117():109898. PubMed ID: 36827925
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.
Xie X; Tang B; Zhou J; Gao Q; Zhang P
Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathway.
Wang HY; Zhang Y; Zhou Y; Lu YY; Wang WF; Xin M; Guo XL
Biomed Pharmacother; 2016 Oct; 83():349-361. PubMed ID: 27416556
[TBL] [Abstract][Full Text] [Related]
6. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the Mechanism of Agrimonolide in Treating Colon Cancer Based on Network Pharmacology.
Yu L; Gai Y
Drug Des Devel Ther; 2023; 17():2209-2222. PubMed ID: 37533972
[TBL] [Abstract][Full Text] [Related]
8. Study on the mechanism of Fufang E'jiao Jiang on precancerous lesions of gastric cancer based on network pharmacology and metabolomics.
Shi WB; Wang ZX; Liu HB; Jia YJ; Wang YP; Xu X; Zhang Y; Qi XD; Hu FD
J Ethnopharmacol; 2023 Mar; 304():116030. PubMed ID: 36563889
[TBL] [Abstract][Full Text] [Related]
9. Reduced Lipocalin 2 Expression Contributes to Vincristine Resistance in Human Colon Cancer Cells.
Guo X; Li Q; Wang YF; Wang TY; Chen SJ; Tian ZW
Recent Pat Anticancer Drug Discov; 2018; 13(2):248-254. PubMed ID: 29268690
[TBL] [Abstract][Full Text] [Related]
10. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
11. Deep sequencing identifies deregulation of microRNAs involved with vincristine drug-resistance of colon cancer cells.
Dong WH; Li Q; Zhang XY; Guo Q; Li H; Wang TY
Int J Clin Exp Pathol; 2015; 8(9):11524-30. PubMed ID: 26617885
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology identification and in Vivo validation of key pharmacological pathways of Phyllanthus reticulatus (Euphorbiaceae) leaf extract in liver cancer treatment.
Tang Y; Sun L; Wei J; Sun C; Gan C; Xie X; Liang C; Peng C; Wu H; Zheng Z; Pan Z; Huang Y
J Ethnopharmacol; 2022 Oct; 297():115479. PubMed ID: 35777610
[TBL] [Abstract][Full Text] [Related]
13. Integrated Metabonomics and Network Pharmacology to Reveal the Action Mechanism Effect of Shaoyao Decoction on Ulcerative Colitis.
Wu J; Luo Y; Shen Y; Hu Y; Zhu F; Wu J; Liu Y
Drug Des Devel Ther; 2022; 16():3739-3776. PubMed ID: 36324421
[TBL] [Abstract][Full Text] [Related]
14. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
15. Saikosaponin B4 Suppression Cancer Progression by Inhibiting SW480 and SW620 Cells Proliferation via the PI3K/AKT/mTOR Pathway in Colon Cancer.
Zhang Y; Lin L; Wang Y; Liu Z; Xia W; Sui H; Fu X
Curr Cancer Drug Targets; 2022; 22(11):889-903. PubMed ID: 35762543
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic role and potential mechanism of EGCG in obesity-related precocious puberty as determined by integrated metabolomics and network pharmacology.
Gu Q; Xia L; Du Q; Shao Y; He J; Wu P; Liang L; Shen X
Front Endocrinol (Lausanne); 2023; 14():1159657. PubMed ID: 37334310
[TBL] [Abstract][Full Text] [Related]
17. Hyperin Enhances the Sensitivity of HCT8/VCR Colon Cancer Cell Line to Vincristine by Down-Regulating P-Glycoprotein.
Wang LM; Zhang MY; Zhu QS; Lu CF; Bai X
Clin Lab; 2018 Mar; 64(3):269-275. PubMed ID: 29739100
[TBL] [Abstract][Full Text] [Related]
18. Study on the molecular mechanism of nightshade in the treatment of colon cancer.
Na S; Ying L; Jun C; Ya X; Suifeng Z; Yuxi H; Jing W; Zonglang L; Xiaojun Y; Yue W
Bioengineered; 2022 Jan; 13(1):1575-1589. PubMed ID: 35012428
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of
Han Z; Huang H; Zhang T
J Cancer Res Ther; 2019; 15(1):38-41. PubMed ID: 30880752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
